Get the Stockscreener App
1.875
4.17%
0.075
Biomerica Inc stock is traded at $1.875, with a volume of 13,059.
It is up +4.17% in the last 24 hours and down -18.48% over the past month.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
See More
Previous Close:
$1.80
Open:
$1.87
24h Volume:
13,059
Relative Volume:
0.90
Market Cap:
$8.62M
Revenue:
$4.33M
Net Income/Loss:
$-4.17M
P/E Ratio:
-1.2539
EPS:
-1.4953
Net Cash Flow:
$-3.19M
1W Performance:
-0.79%
1M Performance:
-18.48%
6M Performance:
-11.14%
1Y Performance:
-34.44%
1-Day Range:
$1.81
$1.915
1-Week Range:
$1.76
$1.90
52-Week Range:
$1.45
$3.2133
Biomerica Inc Stock (BMRA) Company Profile
Name
Biomerica Inc
Sector
Industry
Phone
(949) 379-2875
Address
17571 VON KARMAN AVENUE, IRVINE, CA
Compare BMRA vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
1.875 | 8.62M | 4.33M | -4.17M | -3.19M | -1.4953 |
ABT
Abbott Laboratories
|
104.47 | 180.77B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.28 | 121.88B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
291.70 | 111.89B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.77 | 63.43B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.59 | 49.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-05-26 | Initiated | Citizens | Mkt Outperform |
| Nov-10-20 | Initiated | Colliers Securities | Buy |
| Jan-04-18 | Initiated | B. Riley FBR, Inc. | Buy |
Biomerica Inc Stock (BMRA) Latest News
BIOMERICA INC SEC Filing (Oct 8, 2026) - Stock Titan
CEO and directors bought into Biomerica (BMRA)'s $2.23 million share sale. - Stock Titan
Form S-3 Biomerica Inc For: 26 September By Investing.com - Investing.com Nigeria
Biomerica May Offer Up To $250 Million Of Common Stock, Preferred Stock, Debt Securities, & Warrants - TradingView
Biomerica Files $250 Million Mixed Shelf - marketscreener.com
Biomerica Files $250 Million Mixed Shelf - Yahoo Finance
Form S-3 Biomerica Inc For: 24 September - Investing.com India
Form S-3 Biomerica Inc For: 24 September By Investing.com - Investing.com UK
Biomerica files prospectus for resale of 1.4 million shares - scanx.trade
Biomerica Stock Price Forecast. Should You Buy BMRA? - StockInvest.us
Biomerica Inc. (BMRA) Holds Near $2.36 as Traders Eye Tight RangeDiamond Pattern - siam.in
Biomerica (BMRA) gets new B. Riley-linked shareholder - stocktitan.net
Biomerica (BMRA) finance chief discloses four stock option awards - Stock Titan
Biomerica Raises $2.23 Million as Quarterly Sales Rise 17% - Orange County Business Journal
Biomerica (BMRA) Gains 1.35% as Shares Test Key Level Near $2.36Cash Secured Put - dars.gov.et
BRC Group Holdings, Inc. Buys Biomerica Inc (BMRA) -- Shares Loo - GuruFocus
Biomerica director Gary M. Huff acquires $50,000 in BMRA stock By Investing.com - Investing.com Nigeria
Biomerica director Gary M. Huff acquires $50,000 in BMRA stock By Investing.com - Investing.com Australia
Biomerica director Gary M. Huff acquires $50,000 in BMRA stock - Investing.com
Biomerica director Gary M. Huff acquires $50,000 in BMRA stock By Investing.com - Investing.com India
Biomerica director Gary M. Huff acquires $50,000 in BMRA stock By Investing.com - Investing.com Canada
Biomerica net loss hits USD 3.8M in 2026 - Medical Buyer
BRC Group Holdings Secures 10.03% Activist Stake in BIOMERICA INC (NASDAQ: BMRA) with $736,128 Investment - Kalkine Media
Biomerica reports fiscal 2026 revenue and product updates - grafa.com
Biomerica Reports Q4 Results - Orange County Business Journal
Biomerica Q4 net loss narrows 27%, revenue up 17% to $875K - scanx.trade
Biomerica Reports Fiscal 2026 Fourth-Quarter Sales Growth, Improved Full-Year Loss and Advances in inFoods IBS Commercialization - Quiver Quantitative
Biomerica Reports Fiscal 2026 Fourth-Quarter Sales Growth, Improved Full-Year Loss and Advances in inFoods IBS Commercialization - Quiver Quantitative
BIOMERICA INC FY 2026: Revenue $4.45M, EPS $(1.30) — 10-K Summary - TradingView
Biomerica : Annual Report for Fiscal Year Ending May 31, 2026 (Form 10-K) - marketscreener.com
Biomerica announces USD 2.23M financing - medicalbuyer.co.in
Biomerica, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
B. Riley joins Biomerica (BMRA) as key investor and deal advisor - Stock Titan
Biomerica Inc. (BMRA) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
BRC Group Holdings Secures Board Representation at Biomerica with 10.03% Stake - TradingView
Biomerica director Gary Huff buys $50,000 in common stock By Investing.com - Investing.com Canada
Biomerica director Gary Huff buys $50,000 in common stock By Investing.com - Investing.com South Africa
Biomerica director Gary Huff buys $50,000 in common stock By Investing.com - Investing.com India
Biomerica (BMRA) director joins $1.60 private placement buy - Stock Titan
Biomerica (BMRA) director adds 6,250 shares in private deal - Stock Titan
Biomerica (NASDAQ: BMRA) director adds shares in $1.60 private placement - Stock Titan
Biomerica (NASDAQ: BMRA) director lifts stake to 73,542 shares - Stock Titan
Biomerica (NASDAQ: BMRA) CEO adds 31,250 shares in private placement - Stock Titan
Biomerica Inc. (BMRA) Key Financial Ratios – Valuation, Profitability & More - Value Research
Biomerica raises $2.23 million in private placement at $1.60 - Investing.com
Biomerica Announces $2.23 Million Private Placement at $1.60 per Share and Engages B. Riley to Review Strategic Alternatives - Moomoo
Biomerica Announces $2.23 Million Private Placement at $1.60 per Share and Engages B. Riley to Review Strategic Alternatives - Quiver Quantitative
Biomerica Announces $2.23 Million Private Placement at $1.60 per Share and Engages B. Riley to Review Strategic Alternatives - Quiver Quantitative
Biomerica director Gary Huff buys $50,000 in common stock - Investing.com
Biomerica raises $2.23 million in private placement at $1.60 By Investing.com - Investing.com India
Biomerica Inc Stock (BMRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Biomerica Inc Stock (BMRA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| MOATAZEDI DAVID | Director |
Aug 26 '26 |
Buy |
1.60 |
10,000 |
16,000 |
40,625 |
| Chin Eric | Director |
Aug 26 '26 |
Buy |
1.60 |
6,250 |
10,000 |
38,750 |
| BARBIERI ALLEN | Executive Vice Chairman |
Aug 26 '26 |
Buy |
1.60 |
20,000 |
32,000 |
73,542 |
| Irani Zackary S. | Chief Executive Officer |
Aug 26 '26 |
Buy |
1.60 |
31,250 |
50,000 |
242,570 |
0.98%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):